JAKAVI (Ruxolitinib) 5MG x 30 Tablets
JAKAVI (Ruxolitinib) is a prescription medication used to treat certain conditions related to the immune system, specifically for patients with myelofibrosis and polycythemia vera. It works by inhibiting specific enzymes that play a crucial role in the signaling pathways of the immune system, helping to reduce symptoms and improve quality of life.

Indications
JAKAVI is indicated for the treatment of:

Myelofibrosis
Polycythemia vera


How It Works
Ruxolitinib is a Janus kinase (JAK) inhibitor that selectively inhibits JAK1 and JAK2 enzymes, which are involved in the signaling of various hematopoietic and immune system processes. By blocking these enzymes, JAKAVI helps to decrease inflammation and reduce the overproduction of blood cells.

Dosage and Administration
The recommended dosage of JAKAVI may vary based on the specific condition being treated and the patient's individual response. It is crucial to follow the prescribing physician's instructions regarding dosage and administration.

Possible Side Effects
Like all medications, JAKAVI may cause side effects. Common side effects include:

Headache
Nausea
Fatigue
Diarrhea

Patients should report any severe or persistent side effects to their healthcare provider.

Precautions
Before starting treatment with JAKAVI, inform your healthcare provider about any existing medical conditions, particularly:

Infections
Liver problems
Blood disorders

Regular monitoring may be required during treatment.

Consult Your Doctor
It is essential to consult your healthcare provider for personalized medical advice and to discuss any potential interactions with other medications you may be taking.